Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02296892Phase 3Completed
A Phase 3 trial of remimazolam in Procedural sedation (PS), sponsored by PAION AG. Started Apr 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02296892.